Compare · CCEL vs PGNY
CCEL vs PGNY
Side-by-side comparison of Cryo-Cell International Inc. (CCEL) and Progyny Inc. (PGNY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCEL and PGNY operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- PGNY is the larger of the two at $1.42B, about 17.1x CCEL ($83.3M).
- Over the past year, CCEL is down 36.5% and PGNY is down 20.1% - PGNY leads by 16.4 points.
- PGNY has been more active in the news (5 items in the past 4 weeks vs 2 for CCEL).
- PGNY has more recent analyst coverage (25 ratings vs 0 for CCEL).
- Company
- Cryo-Cell International Inc.
- Progyny Inc.
- Price
- $3.59-2.18%
- $18.18+2.89%
- Market cap
- $83.3M
- $1.42B
- 1M return
- +16.56%
- +2.42%
- 1Y return
- -36.46%
- -20.05%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- 2019
- News (4w)
- 2
- 5
- Recent ratings
- 0
- 25
Cryo-Cell International Inc.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Progyny Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest CCEL
- SEC Form 10-Q filed by Cryo-Cell International Inc.
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
- Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- Cryo-Cell Receives NYSE American Continued Listing Notice
- SEC Form 10-K filed by Cryo-Cell International Inc.
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
- SEC Form 4 filed by Chairman, Co-CEO Portnoy David
- SEC Form 4 filed by Co-CEO Portnoy Mark L.
- SEC Form 4 filed by Chief Information Officer Mikulinsky Oleg
- SEC Form 4 filed by VP Finance, CFO Taymans Jill M
Latest PGNY
- Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
- SEC Form 4 filed by Cummings Melissa B
- Progyny Expands Access to Fertility and Women's Health with Industry's First Fully Insured Supplemental Plan
- SEC Form DEFA14A filed by Progyny Inc.
- SEC Form DEF 14A filed by Progyny Inc.
- Progyny Commemorates 10 Years of Redefining Women's Health and Family Building Care
- SEC Form PRE 14A filed by Progyny Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Progyny Inc.
- SEC Form 4 filed by Clapp Geoffrey
- Progyny Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits